Non-Hodgkin Lymphoma Refractory/ Relapsed
specificA non-Hodgkin lymphoma that does not respond to treatment.
15
Centers
15
Active Trials
—
Cancer Funding
Top Centers for Non-Hodgkin Lymphoma Refractory/ Relapsed(15)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 53.3 |
| 2 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 53.3 |
| 3 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 53.3 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 53.3 |
| 5 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 53.3 |
| 6 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 53.3 |
| 7 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 53.3 |
| 8 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 53.3 |
| 9 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 53.3 |
| 10 | Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive Active Research Program | 53.3 |
| 11 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 53.3 |
| 12 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.3 |
| 13 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 53.3 |
| 14 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 53.3 |
| 15 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 53.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →